Pfizer Inc. is currently facing a multidistrict litigation in the United States involving approximately 400 lawsuits related to its contraceptive injection, Depo-Provera. The lawsuits allege that Pfizer failed to adequately warn women in the U.S. about the increased risk of developing brain tumors, specifically meningiomas, after prolonged use of the drug. This legal action comes in the wake of a study published in March 2024 by EPI-PHARE in the British Medical Journal, which found that women using Depo-Provera for over a year were 5.6 times more likely to develop intracranial meningiomas. Despite adding warning labels in Canada, the UK, and Europe, Pfizer has not issued similar warnings in the U.S. A Case Management Conference is scheduled for May 30 in Pensacola, Florida, as part of the proceedings. The litigation is being supported by the law firm Levin Papantonio.